Recruiting
Neoplasm
RecruitingRegistered drugNo placebo
Long‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
Registered drugNo placebo
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Adagrasib
Find therapies in clinical trials near you
- recruiting
- 3 962
- countries
- 28
- conditions
- 2 101
3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today
57 trials match your criteria
Recruiting
Chronic spontaneous urticaria
RecruitingInvestigationalNo placebo
Remibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial
InvestigationalNo placebo
- Disease:Chronic spontaneous urticaria
- Substances:Remibrutinib
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Remibrutinib
Recruiting
Hidradenitis
RecruitingInvestigational
A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
Investigational
- Disease:Hidradenitis
- Substances:SAR445399
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:SAR445399
Recruiting
Gastrooesophageal cancer+1
RecruitingRegistered drugNo placebo
A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
Registered drugNo placebo
- Disease:Gastrooesophageal cancerOesophageal adenocarcinoma
- Substances:FRUQUINTINIBTrifluridine+1
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:FRUQUINTINIB
Recruiting
Pancreatic carcinoma
RecruitingRegistered drugNo placebo
Study on Chemotherapy for Patients with Resected Pancreatic Cancer Using FOLFIRINOX and Drug Combination
Registered drugNo placebo
- Disease:Pancreatic carcinoma
- Substances:FluorouracilGemcitabine+4
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Fluorouracil
Recruiting
Adenocarcinoma pancreas
RecruitingRegistered drug
Study on Optimizing NALIRIFOX and 5-FU for Metastatic Pancreatic Cancer in First-Line Treatment and Exploring Ciprofloxacin in Second-Line Therapy
Registered drug
- Disease:Adenocarcinoma pancreas
- Substances:CiprofloxacinFluorouracil+5
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Ciprofloxacin
Recruiting
Ovarian epithelial cancer
RecruitingRegistered drugNo placebo
Study on Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Patients with Recurrent Ovarian Cancer
Registered drugNo placebo
- Disease:Ovarian epithelial cancer
- Substances:Cisplatin
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Cisplatin
Recruiting
Adenocarcinoma gastric
RecruitingRegistered drugNo placebo
Study on EXL01 with Nivolumab and FOLFOX for First-Line Treatment in Patients with PD-L1 CPS ≥5 Metastatic Gastric Cancer
Registered drugNo placebo
- Disease:Adenocarcinoma gastric
- Substances:Exl01Fluorouracil Sodium+3
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Exl01
Recruiting
Renal cell carcinoma
RecruitingRegistered drugNo placebo
Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients
Registered drugNo placebo
- Disease:Renal cell carcinoma
- Substances:AxitinibCabozantinib+4
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Axitinib
Recruiting
Breast cancer
RecruitingRegistered drugNo placebo
Study on 68Ga-FAPI-46 for Predicting Treatment Response in Early-Stage High-Risk Triple-Negative Breast Cancer Patients Undergoing Chemo-Immunotherapy
Registered drugNo placebo
- Disease:Breast cancer
- Substances:CarboplatinCyclophosphamide+5
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Carboplatin
Recruiting
Incisional hernia
RecruitingRegistered drug
Study on Botulinum Toxin A Injection for Patients with Large Incisional Hernia
Registered drug
- Disease:Incisional hernia
- Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Recruiting
Colon cancer
RecruitingRegistered drugNo placebo
Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery
Registered drugNo placebo
- Disease:Colon cancer
- Substances:BevacizumabFluorouracil+4
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Bevacizumab